Home Cart Sign in  
Chemical Structure| 945531-77-1 Chemical Structure| 945531-77-1

Structure of Ezutromid
CAS No.: 945531-77-1

Chemical Structure| 945531-77-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Ezutromid is a small utrophin's translation modulator with EC50 of 0.4 μM .

Synonyms: SMT C1100; VOX-C1100; BMN 195

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Ezutromid

CAS No. :945531-77-1
Formula : C19H15NO3S
M.W : 337.39
SMILES Code : O=S(C1=CC=C(OC(C2=CC=C3C=CC=CC3=C2)=N4)C4=C1)(CC)=O
Synonyms :
SMT C1100; VOX-C1100; BMN 195
MDL No. :MFCD30343856

Safety of Ezutromid

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02858362 Duchenne Muscular Dystrophy PHASE2 TERMINATED 2018-09-11 UCLA-David Geffen School of Me... More >>dicine, Los Angeles, California, United States|Children's Hosptial of Colorado, Aurora, Colorado, United States|Nemours Children's Clinic, Orlando, Florida, United States|Boston Children's Hospital, Boston, Massachusetts, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Oregon Health and Science University, Portland, Oregon, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|University of Utah Hospital and Clinics, Salt Lake City, Utah, United States|Heart of England NHS Foundation Trust - Heartlands Hospital, Birmingham, United Kingdom|Bristol Children's Hospital, Bristol, United Kingdom|Addenbrooke's Hospital, Cambridge, United Kingdom|Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom|Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom|Royal Manchester Children's Hospital - Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom|The Freeman Hospital, Newcastle Upon Tyne Hospitals, Newcastle, United Kingdom Less <<
NCT02056808 Duchenne Muscular Dystrophy PHASE1 COMPLETED 2025-07-14 Heart of England NHS Foundatio... More >>n Trust - Heart Lands Hospital, Birmingham, B9 5SS, United Kingdom|Alder Hey Children's NHS Foundation Trust, Liverpool, L12 2AP, United Kingdom|Great Ormond Street for Children NHS Foundation Trust, London, United Kingdom|Central Manchester University Hospitals NHS Foundation Trust- Royal Manchester Children's Hospital, Manchester, United Kingdom Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.96mL

0.59mL

0.30mL

14.82mL

2.96mL

1.48mL

29.64mL

5.93mL

2.96mL

References

 

Historical Records

Categories